Experimental and clinical studies of left heart bypass using a centrifugal pump. Application as adjunct in operation for thoracic aortic aneurysms.
10.4326/jjcvs.20.442
- VernacularTitle:遠心ポンプを用いた左心バイパスの実験的臨床的検討 胸部大動脈手術の補助手段への応用
- Author:
Noboru MURATA
;
Noboru YAMAMOTO
;
Atsubumi MURAKAMI
;
Hideo YOKOKAWA
;
Makoto FUNAMI
;
Toshihiro TAKABA
- Publication Type:Journal Article
- From:Japanese Journal of Cardiovascular Surgery
1990;20(3):442-448
- CountryJapan
- Language:Japanese
-
Abstract:
Left heart bypass was performed with Bio Medicus Co.-made Bio-pump, a representative centrifugal pump. A vinyl chloride tube for the usual cardio-pulmonary bypass not treated with antithrombogenic material. was used in the bypass circuit. In the experiment, the mongreal adult dogs were divided into the systemic heparinized group and non-heparinized group and the bypass was performed for 6 hours. As a result, coagulation and fibrinolysis were more activated in the non-heparinized group than the other group. So, when this method is used clinically, a small quantity of heparin should be administered. Clinically, this approach was used as an adjunct in operation for 7 cases of thoracic aortic aneurysm. During left heart bypass, a small quantity of heparin (0.5-1.0mg/kg) was administered. A rise in FPA and FDP considered attributable to autotransfusion during the operation was noted. Distal perfusion could be performed fully and the amount of bleeding during and after operation was small, but 1 case each of acute renal failure and paraplegia as postoperative complication was encountered. Neither was considered due to left heart bypass; and, changes in respiratory system and hepato-renal function were considered within the tolerable range. These results have led us to believe that left heart bypass using Bio-pump is safe and useful as an adjunct in operation for thoracic aortic aneurysm and should be used positively in the future.
